FDA Denies Tab-Cel Approval in PTLD
FDA Issues New CRL for Tabelecleucel in Epstein Barr Virus–Positive PTLD
| Read More |
Atezolizumab Combo Does Not Significantly Boost Survival in Ovarian Cancer
| Read More |
Videos
 Mobile Unit Seeks to Bolster Prostate Cancer Testing Among At-Risk Groups
|
 Collaboration May Expedite ctDNA Use and Inform Adjuvant Rectal Cancer Care
|
Trending
 What Were The Key Kidney and Bladder Cancer Advances in 2025?
|
 New Treg Therapy Earns FDA Orphan Drug Designation in Myelofibrosis
|